Key opinion leaders shared their perspectives on the surgical and technological advances in cataract, cornea, glaucoma, refractive surgery, IOLs, age-related macular degeneration and more at Kiawah Eye 2015.
Uncategorized
Uncategorized
OSN Europe: Dysphotopsias require separate management strategies
Negative dysphotopsia, or ND, represents an undesired optical phenomenon after cataract surgery. It is classically described as a dark temporal shadow. Conversely, positive dysphotopsia, or PD, is characterized by light streaks, star bursts or glare. B…
Senate Passes Bill Protecting ASC Docs From MU Penalties
The legislation would exempt surgeons from a key requirement until ambulatory surgery centers have certified EHRs. Medscape Medical News
Uncategorized
Femtosecond laser-assisted cataract surgery may alter aqueous humor pH values
Researchers found an acidic shift in aqueous humor pH values during femtosecond laser-assisted cataract surgery due to cavitation bubbles produced during the procedure.The researchers prospectively compared aqueous humor pH values in 29 patients random…
Uncategorized
Bruker Names Dr. Hermann Requardt to Board of Directors
BILLERICA, Mass.–(BUSINESS WIRE)–Bruker Corporation (NASDAQ: BRKR) today announced that it has appointed Dr. Hermann Requardt to its Board of Directors effective immediately. Dr. Requardt will serve for an initial term expiring at the Company’s 2017 Annual Meeting of Stockholders. Dr. Requardt currently serves as an independent strategic advisor to a number of European public and private life science and healthcare technology companies. From 2009 to February 2015, he served as Chief Executive
Uncategorized
Enrollment complete for Glaukos iStent inject pivotal trial
Enrollment in an investigational device exemption trial for the iStent inject is complete, according to a Glaukos press release.The prospective multicenter trial includes 500 patients with glaucoma and cataracts randomized to receive both iStent inject…